DOJ requests federal appeals court to block grant of stay for Texas' abortion law; common synthetic chemicals linked with premature death; influenza hospitalization and death more likely in pediatric minority populations.
As reported by CBS News, the Department of Justice (DOJ) requested the 5th Circuit Court of Appeals to block the Texas abortion law from going into effect after it was granted a temporary reinstatement last week by a 3-judge panel on the federal appeals court. Following a temporary injunction on October 6 that blocked the enforcement of the law as the case proceeds, the temporary stay issued by the lower court’s ruling came 2 days later, which bans abortions after 6 weeks into a pregnancy–often before many women know they are pregnant. The DOJ argued the law is unconstitutional and said that its reinstatement would cause irreparable harm to individuals.
According to a new study published Tuesday in Environmental Pollution, synthetic chemicals called phthalates, which are found in consumer products such as shampoo, makeup, perfume, and children’s toys, were linked with premature deaths among 91,000 to 107,000 US adults aged 55 to 64 per year. Reported by CNN, findings of the study indicated that those with the highest levels of phthalates exposure were at greater risk of death from any cause, particularly cardiovascular mortality. Study authors estimated $40-$47 billion in lost economic productivity were linked with the associated deaths.
As flu season begins to take shape amid lingering fears of COVID-19, an article by The Washington Post highlighted findings of a recent study indicating that young children who are Black, Hispanic, or American Indian/Alaska Native are more likely than White children to be hospitalized and die from influenza. Results of the JAMA Network Open study were based on 113,352 flu hospitalizations in the United States between 2009 and 2019, with the greatest disparities found in children younger than 5 whose in-hospital mortality was 3 to 4 times higher in minority groups compared with non-Hispanic White children.
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More